ARMKAramark
- Next report
- Nov 16
- Monday, in 4 days · before the market opens
- EPS expected
- $0.75
- quarter ending Sep 30, 2026
- Last result
- $0.52Beat
- vs $0.48 expected on Aug 11
- Stock move on it
- +8.54%
- one session
- Price
- $53.86
- +0.13% today · $14.3B cap
Past and upcoming reports
2
| Nov 16, 2026 | Sep 30, 2026 | Before the market opens | $0.75 | not yet | |
| Aug 11, 2026 | Jun 30, 2026 | Time not given | $0.48 | Beat$0.52 | +8.54% |
Pre-earnings read
We have a note ready for the Nov 16, 2026 report: what we expect it to earn per share, how the stock may react and what to watch. It is part of the full report, which a free account gets on three stocks you pick and Pro gets on every stock. See both plans
After the report
Aug 11, 2026 report
Aramark beat EPS estimates, but valuation and thin margins leave execution as the next test
Aramark reported $0.52 EPS for the quarter ended June 30, beating the $0.48 estimate by 8.3%. Shares rose 2.12% to $62.40 on August 14, while the event-day reaction was unavailable. Forward growth expectations support the thesis, but a 4.31% operating margin, 1.96 debt-to-equity ratio, and RSI of 85.65 raise execution and valuation risks.
Reported against expected
BeatReported EPS was $0.52 versus the $0.48 estimate, a $0.04 or 8.3% beat, reported August 11 for the quarter ended June 30.
Guidance
RaisedThe payload identifies raised-outlook follow-through as the catalyst, but provides no explicit guidance figures or quantified change.
How the stock reacted
The event-day, first-day, and second-day reactions were unavailable. shares were up 2.12% at $62.40 on August 14.
What changed
EPS was $0.52, beating estimates by 8.3%, while raised-outlook follow-through became the next catalyst.
What the price now assumes
A 2.12% share gain and 20.84 forward P/E indicate support for growth despite RSI reaching 85.65.
What it means for the business
Maintain a constructive bias only if raised outlook converts into further earnings growth without margin deterioration.
The next one to three months, as we saw it then
Better case40%
The EPS beat and 19.69% next-year EPS growth forecast support continued rerating if management delivers on its raised outlook.
Base case35%
The beat supports earnings momentum, but a 41.81 trailing P/E and overbought RSI may limit near-term upside without additional guidance evidence.
Worse case25%
A modest 4.31% operating margin and heavy leverage could amplify downside if revenue growth slows or costs rise.
If you hold it
Hold unless the next quantified outlook update shows margin deterioration from 4.31% or materially lowers the 19.69% next-year EPS growth outlook.
If you are watching
Add only if raised-outlook follow-through is quantified and operating margin improves. do not trade if guidance remains unquantified while RSI stays at 85.65.
Scenario odds are a judgement, not measured.